Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPOTAR-07: Lipid Metabolism in ARV-naive HIV Patients
NCT00759070Phase 4Unknown
- Start
- Sep 2008
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of efavirenz, lopinavir and ritonavir in human immunodeficiency virus infection (HIV) (2 arms). Primary endpoint: Changes in total cholesterol and HDL and LDL fractions at 48 weeks. Status: unknown.
02
Drugs
efavirenzlopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00759070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759070.